|
Age (mean ± SD), years
|
61.5 ± 12.1
|
|
Sex, n (%)
| |
|
Male
|
163 (62.0)
|
|
Female
|
100 (38.0)
|
|
BMI (mean ± SD), kg/m2
|
23.5 ± 3.3
|
|
Diabetic mellitus, n (%)
|
47 (17.9)
|
|
Hypertension, n (%)
|
89 (33.8)
|
|
History of surgery, n (%)
|
79 (30.0)
|
|
Smoking, n (%)
|
61 (23.2)
|
|
Alcohol, n (%)
|
77 (29.3)
|
|
Preoperative jaundice, n (%)
|
103 (39.2)
|
|
Preoperative biliary drainage, n (%)
|
77 (29.3)
|
|
ALT (median, IQR), U/L
|
45.5 (17.8–102.8)
|
|
AST (median, IQR), U/L
|
30.3 (17.9–63.5)
|
|
AKP (median, IQR), U/L
|
141.2 (69.5–290.2)
|
|
γ-GGT (median, IQR), U/L
|
130.6 (22.9–387.8)
|
|
TB (median, IQR), μmol/L
|
16.0 (9.2–58.6)
|
|
DB (median, IQR), μmol/L
|
6.5 (2.3–45.2)
|
|
Albumin (mean ± SD), g/L
|
38.8 ± 3.1
|
|
WBC(mean ± SD), × 109/L
|
5.8 ± 1.8
|
|
Hemoglobin (mean ± SD), g/L
|
122.8 ± 17.9
|
|
Platelet(mean ± SD), × 109/L
|
230.9 ± 86.8
|
|
Pathology diagnosis, n (%)
| |
|
VAC
|
94 (35.7)
|
|
PDAC
|
61 (23.2)
|
|
DCC
|
24 (9.1%)
|
|
IPMN
|
25 (9.5%)
|
|
SCN
|
10 (3.8%)
|
|
pNET
|
9 (3.4%)
|
|
SPN
|
6 (2.3%)
|
|
MCN
|
4 (1.5%)
|
|
CP
|
4 (1.5%)
|
|
Others
|
26 (9.9%)
|
|
Surgical method, n (%)
| |
|
PD
|
186 (70.7)
|
|
PPPD
|
77 (29.3)
|
|
Vessel resection, n (%)
| |
|
Yes
|
9 (3.4)
|
|
No
|
254 (96.6)
|
|
Pancreatic texture
| |
|
Firm
|
36 (13.7)
|
|
Soft
|
227 (86.3)
|
|
Diameter of the MPD (mm)
|
3.0 (2.0–5.0)
|
|
Fistula risk score
|
6.0 (4.0–7.0)
|
|
Operating time (mean ± SD), min
|
379.4 ± 96.9
|
|
Blood loss volume (median, IQR), ml
|
400.0 (300.0–700.0)
|
|
Blood transfusion (median, IQR), ml
|
0.0 (0.0–700.0)
|
|
CR-POPF, n (%)
|
99 (37.6)
|
|
Biliary leakage, n (%)
|
16 (6.1)
|
|
DGE, n (%)
|
94 (35.7)
|
|
PPH, n (%)
|
22 (8.4)
|
|
Chylous fistula, n (%)
|
31 (11.8)
|
|
Major postoperative complications, n (%)
|
57 (21.7)
|
|
Wound infection, n (%)
|
14 (5.3)
|
|
Intra-abdominal infection, n (%)
|
106 (40.3)
|
|
Bacteremia, n (%)
|
14 (5.3)
|
|
Pneumonia, n (%)
|
8 (3.0)
|
|
Urinary tract infection, n (%)
|
3 (1.4)
|
